About THC BioMed
THC BioMed is a company based in Kelowna (Canada) founded in 1982. THC BioMed has completed 1 acquisition, including Cloneshipper. THC BioMed offers products and services including Dry Flowers, Edibles, Pre-Rolls, and Genetic Strains. THC BioMed operates in a competitive market with competitors including Flowr, Wayland, Avant Brands, Primo Brands Inc and Canveda, among others.
- Headquarter Kelowna, Canada
- Stage Public
-
Sectors
Consumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Thc Biomed Intl Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$400 K (USD), Post-IPO
Nov 20, 2017
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of THC BioMed
THC BioMed offers a comprehensive portfolio of products and services, including Dry Flowers, Edibles, Pre-Rolls, and Genetic Strains.
High-quality dried cannabis flowers for medical and recreational use.
Cannabis-infused edibles like KISS for consumption.
Pre-rolled cannabis joints for convenient use.
Strains for growing or purchasing finished products.
Funding Insights of THC BioMed
Investors in THC BioMed
THC BioMed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Global Emerging Markets.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked |
Investor details for THC BioMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by THC BioMed
THC BioMed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cloneshipper.
Investment portfolio details for THC BioMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online platform offering plant shipping containers
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for THC BioMed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - THC BioMed
Detailed financials for THC BioMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thc Biomed Comparisons
Peer comparison for THC BioMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of THC BioMed
THC BioMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flowr, Wayland, Avant Brands, Primo Brands Inc and Canveda, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis products are supplied in the Canadian market.
|
|
| Locked | Locked | Locked |
Manufactures high-quality medical cannabis products for healthcare applications.
|
|
| Locked | Locked | Locked |
Administrative services for cannabis industries are provided by GTEC.
|
|
| Locked | Locked | Locked |
Develops and sells premium CBD-infused cannabis products for health benefits.
|
|
| Locked | Locked | Locked |
Provides high-quality medical cannabis products through online sales and delivery.
|
Detailed competitors of THC BioMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thc Biomed
Complete news archive for THC BioMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about THC BioMed
THC BioMed was founded in 1982 and raised its 1st funding round 35 years after it was founded.
THC BioMed is headquartered in Kelowna, Canada. It is registered at Kelowna, British Columbia, Canada.
John Miller is the current CEO of THC BioMed.
THC BioMed is developing medical cannabis products. The company is a licensed producer of medical marijuana. Products developed include delahaze, sweet purple, wappa, etc.
THC BioMed's top competitors include Flowr, Avant Brands and Wayland.
THC BioMed offers Dry Flowers, Edibles, Pre-Rolls, and Genetic Strains.
THC BioMed has made 1 acquisition, including Cloneshipper.
THC BioMed has 1 investor. Key investors include Global Emerging Markets.